Gilead Sciences, Inc.GILDNASDAQ
Loading
Revenue PerformanceStable
Percentile Rank86
3Y CAGR+2.6%
5Y CAGR+3.6%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
+2.6%/yr
vs +5.4%/yr prior
5Y CAGR
+3.6%/yr
Consistent
Acceleration
-2.8pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $29.44B | +2.4% |
| 2024 | $28.75B | +6.0% |
| 2023 | $27.12B | -0.6% |
| 2022 | $27.28B | -0.1% |
| 2021 | $27.30B | +10.6% |
| 2020 | $24.69B | +10.0% |
| 2019 | $22.45B | +1.5% |
| 2018 | $22.13B | -15.2% |
| 2017 | $26.11B | -14.1% |
| 2016 | $30.39B | - |